Skip to main content
  • First Child Vaccinated with Typhoid Conjugate Vaccine in Africa

    UMSOM Vaccine Expert Leading Typhoid Project

    Learn More
  • UMSOM’s Monica McArthur, MD, PhD. Discusses Zika Virus and Challenges in Developing a Vaccine

    Learn More
  • IGH Director Kathleen Neuzil, MD, Discusses This Year’s Influenza Season

    UMSOM Expert Discusses Advances in Influenza Vaccine Research and Development

    Learn More
  • Zika Vaccine on the Horizon Thanks in Part to Work by Our IGH Researchers

    Gene-based Zika vaccine is safe and immunogenic in healthy adults

    Learn More
  • University of Maryland School of Medicine Researchers Studying New Approach to Fighting Antibiotic-resistant Wound Infections

    U.S. military-funded research could help stave off drug-resistant staph infections

    Learn More
  • UM SOM Scientist Awarded Roux Prize for Vaccine Work in Mali

    Samba Sow, MD, Msc Recognized for Saving the Lives of Children in Mali Through Hib Vaccination Program

  • UM SOM Vaccine Expert Warns of Risks of Influenza to Older Populations

    CVD Director Kathleen Neuzil Says People 65 and Older Risk Severe Complications from Influenza

    Learn More
  • UM SOM Research Supports New Approach for Protecting Infants from Malaria

    Targeting Pregnant Women Against Malaria Through Vaccination Could Protect Infants

    Learn More
  • UM School of Medicine Receives $2 Million Grant for HIV Research in Malawi

    Researchers Will Study Impact of HIV Exposure During Pregnancy on Infant Immune Development

    Learn More
  • UM SOM Pediatrics Infectious Disease Specialist Receives J. Tyson Tildon Award for Excellence in Pediatric Research

    Division of Malaria Research Director Recognized for Global Child Health Research

  • Diagnosing, preventing, treating, controlling, eliminating and eradicating diseases of global impact

  • Collaborating with other UMSOM Institutes, Centers, Departments and Programs, and other UMB and University of Maryland System Schools

  • High-Dose Cholera Vaccine Developed by UMSOM Scientists Shows Promise for Controlling Outbreaks

    Single-dose vaccine could provide faster protection in cholera epidemics


Institute for Global Health (IGH)

About the IGH

The IGH, established in 2015 at the University of Maryland School of Medicine, is dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world.

A Global Foot Print:
Current Research and Development

(mouse over red markers  to learn about each of our global research projects)

Click Here for a full-screen map

Within the IGH is the Center for Vaccine Development (CVD), which is led by Kathleen Neuzil, MD, MPH, and the Division of Malaria Research, which under the leadership of Miriam Laufer, M.D.

For over 40 years, CVD has worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.The Division of Malaria Research performs the crucial work needed to support global malaria eradication. That work includes developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. The IGH is an instrumental partner in international initiatives to eliminate malaria in Africa and other parts of the world. 

With more than 30 faculty physicians and scientists, the IGH collaborates with other School of Medicine institutes, centers, departments and programs, as well as other schools on campus, and other entities within the University System of Maryland.

Give to IGH

Kathleen Neuzil, MD, MPH, FIDSA

Kathleen M. Neuzil, MD, MPH, FIDSA
IGH Interim Director

Connect with IGH

IGH News

Global Health Seminar

Kenneth Leonard, PhD, Associate Professor, Agricultural and Resource Economics, University of Maryland College Park

Dr. Leonard will discuss Challenges and Solutions for Primary Health Care in Low Resource Settings.

February 19, 2018 at noon
HSFII Auditorium
20 Penn Street

IGH News